K-number	K020920
Device name	COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE
Applicant	Cozart Bioscience , Ltd.
Product code	DJG
Device class	Class II
Decision date	Nov 5, 2002
Decision	Substantially Equivalent
Regulation	862.3650

AI Summary

AI extraction for this record is queued and will appear within 24 hours. View full FDA record →

Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?

Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.

Start free trial →

Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →

COZART RAPISCAN ORAL FLUID DRUG TEST - OPIATE/METHADONE

Everything you need for a 510(k) submission. Nothing you don't.